Aortic Stenosis: 200 Newly Identified Genes Raise Hope For Future Treatments

A groundbreaking new study has identified over 200 genes linked to aortic stenosis, the most common form of heart valve disease. This discovery, published in Nature Genetics, offers a potential pathway toward earlier detection and the development of targeted treatments for this currently incurable condition.

Unlocking the Genetic Code of Aortic Stenosis

The research, a meta-analysis integrating genetic data from 2.8 million individuals across diverse ancestral groups, represents the largest genetic analysis of aortic stenosis to date. It was co-led by Dr. George Thanassoulis, and Dr. Jamie Engert of the Cardiovascular Health across the Lifespan research Program at the Research Institute of the McGill University Health Centre (The Institute), in collaboration with Harvard University and other international researchers.

Currently, treatment for aortic stenosis focuses on managing symptoms – such as shortness of breath, chest pain, palpitations, and dizziness – with medication. However, these treatments do not halt the disease’s progression. The only interventions are heart valve replacement through open-heart surgery or a catheter procedure, options that carry risks and aren’t suitable for all patients.

A New Risk Score and Potential for Early Intervention

Researchers created a risk score based on the identified genes, which could predict an individual’s probability of developing aortic stenosis. Dr. Thanassoulis explained that this tool “could improve screening for people at high risk of developing the disease, even before symptoms appear.” This early identification could allow for earlier intervention and potentially prevent the need for valve replacement.

The study also revealed that certain genes disrupt biological processes crucial to the disease, including inflammation, calcification, lipid metabolism, adiposity, and cell division cycle arrest. Notably, the team identified two genes that, when deactivated, blocked calcium accumulation in valve cells.

Dr. Engert emphasized the strengths of the study, stating, “Our study has several major strengths: the inclusion of a large number of individuals, its multi-ancestral design, and the separate analysis of men and women, which enhanced our ability to detect genetic markers within different populations.” The team also identified three genes that may explain differences in how the disease develops in men versus women.

What Could Happen Next?

The identification of these genes is likely to spur further research into the underlying mechanisms of aortic stenosis. Researchers may now focus on testing drugs in preclinical models to determine if they can effectively target these genes and prevent or slow disease progression. Clinical trials could also be designed to select participants based on their genetic risk scores, potentially leading to more effective preventative strategies.

Frequently Asked Questions

What is aortic stenosis?

Aortic stenosis is characterized by thickening, hardening, calcification, and/or narrowing of the aortic valve, the opening between the left ventricle of the heart and the aorta.

How common is aortic stenosis in Canada?

Aortic stenosis affects nearly 3% of people aged 65 and older in Canada.

What was the size of the genetic dataset used in this study?

The study integrated genetic data from 2.8 million individuals from diverse populations belonging to different ancestral groups.

Could a deeper understanding of the genetic factors contributing to aortic stenosis revolutionize how we approach this challenging heart condition?